FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022657624> ?p ?o ?g. }

• W2022657624 endingPage "4905" @default.
• W2022657624 startingPage "4900" @default.
• W2022657624 abstract "ABSTRACT ST-246 is being evaluated as a treatment for pathogenic orthopoxvirus infections in humans. To this end, a phase 2, double-blind, randomized, placebo-controlled, multicenter trial was conducted to assess the safety, tolerability, and pharmacokinetics (PK) of ST-246 when administered as a single daily oral dose (400 mg or 600 mg) for 14 days in fed adult volunteers. ST-246 was safe and well tolerated, with no deaths or serious adverse events reported during the study. There was a low incidence of treatment-emergent adverse events (TEAEs), the most common of which were mild nausea and headache. There were no clinically significant results from laboratory assessments, vital sign measurements, physical examinations, or electrocardiograms. The PK and dose proportionality of ST-246 were determined. The PK analysis showed that steady state was achieved by day 5 for the ST-246 400-mg treatment group and by day 6 for the 600-mg group. The dose proportionality analysis showed that the 400- and 600-mg ratio of dose-normalized peak drug concentration in plasma ( C max ) and relative exposure for each dosing interval (AUC τ ) ranged from 80% to 85%. However, the 90% confidence intervals did not include 1.0, so dose proportionality could not be concluded. Overall, ST-246 was shown to be safe, and the PK was predictable. These results support further testing of ST-246 in a multicenter pivotal clinical safety study for licensure application." @default.
• W2022657624 created "2016-06-24" @default.
• W2022657624 creator A5005656404 @default.
• W2022657624 creator A5005801857 @default.
• W2022657624 creator A5008001331 @default.
• W2022657624 creator A5009482073 @default.
• W2022657624 creator A5011600825 @default.
• W2022657624 creator A5018550848 @default.
• W2022657624 creator A5023360994 @default.
• W2022657624 creator A5028366409 @default.
• W2022657624 creator A5037520371 @default.
• W2022657624 creator A5039260589 @default.
• W2022657624 creator A5039657267 @default.
• W2022657624 creator A5042474549 @default.
• W2022657624 creator A5060891849 @default.
• W2022657624 creator A5077224683 @default.
• W2022657624 creator A5081749777 @default.
• W2022657624 creator A5082551727 @default.
• W2022657624 creator A5083472255 @default.
• W2022657624 date "2012-09-01" @default.
• W2022657624 modified "2023-10-18" @default.
• W2022657624 title "Safety and Pharmacokinetics of the Anti-Orthopoxvirus Compound ST-246 following a Single Daily Oral Dose for 14 Days in Human Volunteers" @default.
• W2022657624 cites W1576590852 @default.
• W2022657624 cites W1981060305 @default.
• W2022657624 cites W1985149546 @default.
• W2022657624 cites W1997782497 @default.
• W2022657624 cites W2064879261 @default.
• W2022657624 cites W2077979585 @default.
• W2022657624 cites W2092565749 @default.
• W2022657624 cites W2104341592 @default.
• W2022657624 cites W2105880360 @default.
• W2022657624 cites W2114782042 @default.
• W2022657624 cites W2118488619 @default.
• W2022657624 cites W2136561168 @default.
• W2022657624 cites W2136580520 @default.
• W2022657624 cites W2158761266 @default.
• W2022657624 doi "https://doi.org/10.1128/aac.00904-12" @default.
• W2022657624 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3421894" @default.
• W2022657624 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22777041" @default.
• W2022657624 hasPublicationYear "2012" @default.
• W2022657624 type Work @default.
• W2022657624 sameAs 2022657624 @default.
• W2022657624 citedByCount "42" @default.
• W2022657624 countsByYear W20226576242013 @default.
• W2022657624 countsByYear W20226576242014 @default.
• W2022657624 countsByYear W20226576242015 @default.
• W2022657624 countsByYear W20226576242016 @default.
• W2022657624 countsByYear W20226576242017 @default.
• W2022657624 countsByYear W20226576242018 @default.
• W2022657624 countsByYear W20226576242019 @default.
• W2022657624 countsByYear W20226576242020 @default.
• W2022657624 countsByYear W20226576242022 @default.
• W2022657624 countsByYear W20226576242023 @default.
• W2022657624 crossrefType "journal-article" @default.
• W2022657624 hasAuthorship W2022657624A5005656404 @default.
• W2022657624 hasAuthorship W2022657624A5005801857 @default.
• W2022657624 hasAuthorship W2022657624A5008001331 @default.
• W2022657624 hasAuthorship W2022657624A5009482073 @default.
• W2022657624 hasAuthorship W2022657624A5011600825 @default.
• W2022657624 hasAuthorship W2022657624A5018550848 @default.
• W2022657624 hasAuthorship W2022657624A5023360994 @default.
• W2022657624 hasAuthorship W2022657624A5028366409 @default.
• W2022657624 hasAuthorship W2022657624A5037520371 @default.
• W2022657624 hasAuthorship W2022657624A5039260589 @default.
• W2022657624 hasAuthorship W2022657624A5039657267 @default.
• W2022657624 hasAuthorship W2022657624A5042474549 @default.
• W2022657624 hasAuthorship W2022657624A5060891849 @default.
• W2022657624 hasAuthorship W2022657624A5077224683 @default.
• W2022657624 hasAuthorship W2022657624A5081749777 @default.
• W2022657624 hasAuthorship W2022657624A5082551727 @default.
• W2022657624 hasAuthorship W2022657624A5083472255 @default.
• W2022657624 hasBestOaLocation W20226576241 @default.
• W2022657624 hasConcept C112705442 @default.
• W2022657624 hasConcept C126322002 @default.
• W2022657624 hasConcept C142724271 @default.
• W2022657624 hasConcept C197934379 @default.
• W2022657624 hasConcept C204787440 @default.
• W2022657624 hasConcept C27081682 @default.
• W2022657624 hasConcept C2777288759 @default.
• W2022657624 hasConcept C2778375690 @default.
• W2022657624 hasConcept C42219234 @default.
• W2022657624 hasConcept C44249647 @default.
• W2022657624 hasConcept C71924100 @default.
• W2022657624 hasConcept C98274493 @default.
• W2022657624 hasConceptScore W2022657624C112705442 @default.
• W2022657624 hasConceptScore W2022657624C126322002 @default.
• W2022657624 hasConceptScore W2022657624C142724271 @default.
• W2022657624 hasConceptScore W2022657624C197934379 @default.
• W2022657624 hasConceptScore W2022657624C204787440 @default.
• W2022657624 hasConceptScore W2022657624C27081682 @default.
• W2022657624 hasConceptScore W2022657624C2777288759 @default.
• W2022657624 hasConceptScore W2022657624C2778375690 @default.
• W2022657624 hasConceptScore W2022657624C42219234 @default.
• W2022657624 hasConceptScore W2022657624C44249647 @default.
• W2022657624 hasConceptScore W2022657624C71924100 @default.
• W2022657624 hasConceptScore W2022657624C98274493 @default.
• W2022657624 hasIssue "9" @default.
• W2022657624 hasLocation W20226576241 @default.

• next